Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Drug Pricing in the United States: How and Why is it Different Than in the Rest of the World

Session Chair(s)

Christopher  Marrone, PharmD, RPh

Christopher Marrone, PharmD, RPh

Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO)

Eli Lilly and Company, United States

Drug Pricing in the United States continues to be a hotly debated subject. As candidates head into the US 2020 election, the topic will only garner more attention. This session will review the differences in worldwide drug pricing regulations and practices. The future landscape of drug pricing in the United States will be discussed, with a review of drug pricing proposals.

Learning Objective : Compare US and non-US drug pricing regulations; Discuss the future landscape of US drug pricing;

Speaker(s)

Scott  Roberts, MBA

Global Perspective: Benchmarking Prescription Drug Price and Access Around the World

Scott Roberts, MBA

Citrus Health Group, United States

Managing Partner

Johann  Odermann

Pharmaceutical Pricing in the US Healthcare Market

Johann Odermann

JustSo Marketing, United States

Principal

Aria  Cohen, MBA

Patient Affordability: Caught at the Intersection of Manufacturer and “System” Dynamics in Specialty Products

Aria Cohen, MBA

Apellis Pharmaceuticals, United States

Senior Director, US Market Access

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.